\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ had\\ subsequent\\ penile\\ revascularization\\ surgery\\ to\\ correct\\ for\\ erectile\\ dysfunction\\.\ \(0\)\
\-\ the\\ paired\\ dorsal\\ arteries\\ and\\ cavernosal\\ arteries\\ of\\ the\\ penis\\ arise\\ from\\ the\\ internal\\ pudendal\\ arteries\\ bilaterally\\.\\ \\ the\\ cavernosal\\ branches\\ are\\ inferior\\ to\\ the\\ dorsal\\ branches\\ and\\ somewhat\\ smaller\\ in\\ caliber\\.\\ \\ \ \(0\)\
\-\ in\\ this\\ patient\\ selective\\ arteriograms\\ of\\ the\\ internal\\ pudendal\\ arteries\\ demonstrates\\ congenital\\ abscence\\ of\\ the\\ right\\ cavernosal\\ artery\\.\\ \\ notice\\ that\\ the\\ right\\ dorsal\\ artery\\ of\\ the\\ penis\\ is\\ hypertrophied\\ to\\ help\\ compensate\\ for\\ limited\\ blood\\ flow\\ to\\ the\\ right\\ crura\\ of\\ the\\ penis\\.\ \(0\)\
\-\ congenital\\ absence\\ of\\ the\\ right\\ cavernosal\\ artery\\ causing\\ erectile\\ dysfunction\ \(0\)\
\-\ congenital\\ absence\\ of\\ the\\ right\\ cavernosal\\ artery\\ \ \(0\)\
\-\ post\\ traumatic\\ occlusion\\ of\\ the\\ right\\ cavernosal\\ artery\\ \ \(0\)\
\-\ thrombosis\\ of\\ or\\ embolization\\ to\\ the\\ right\\ cavernosal\\ artery\\ \ \(0\)\
\-\ vasculidity\\ or\\ vasculopathy\\ affecting\\ the\\ right\\ cavernosal\\ artery\ \(0\)\
\-\ 36\\ year\\ old\\ african\\ american\\ male\\ with\\ long\\ history\\ of\\ difficulty\\ attaining\\ a\\ penile\\ erection\\ without\\ medications\\.\ \(0\)\
\-\ patient\\ demonstrated\\ erectile\\ dysfunction\\ secondary\\ compromised\\ arterial\\ inflow\\.\\ \\ young\\ patients\\ are\\ amenable\\ to\\ penile\\ revascularization\\ with\\ a\\ subjective\\ effectiveness\\ of\\ 40\\-85\\%\\.\ \(0\)\
\-\ kawanishi\\,\\ y\\,\\ kimura\\,\\ k\\,\\ nakanishi\\,\\ r\\,\\ kojima\\,\\ k\\,\\ and\\ numata\\,\\ a\\.\\ \\ \\"penile\\ revasculariztaion\\ surgery\\ for\\ arteriogenic\\ erectile\\ dysfunction\\:\\ \\ the\\ long\\ term\\ efficacy\\ rate\\ calculated\\ by\\ survival\\ analysis\\"\\.\\ \\ bju\\ international\\.\\ \\ volume\\ 94\\.\\ \\ issue\\ 3\\.\\ \\ august\\ 2004\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cavernosal\\:\\ 0\\.28751756613828505\ \(0\)\
\-\ erectile\\:\\ 0\\.13149069137781605\ \(0\)\
\-\ penile\\:\\ 0\\.11527315630039739\ \(0\)\
\-\ penis\\:\\ 0\\.08403466956874112\ \(0\)\
\-\ dysfunction\\:\\ 0\\.08058121321991474\ \(0\)\
\-\ artery\\:\\ 0\\.07881287586175838\ \(0\)\
\-\ pudendal\\:\\ 0\\.0780134373802345\ \(0\)\
\-\ arteries\\:\\ 0\\.06260891619001736\ \(0\)\
\-\ revascularization\\:\\ 0\\.06079299358328482\ \(0\)\
\-\ dorsal\\:\\ 0\\.05773818989352099\ \(0\)\
\-\ congenital\\:\\ 0\\.041484411101448286\ \(0\)\
\-\ branches\\:\\ 0\\.04134852829712359\ \(0\)\
\-\ k\\:\\ 0\\.0412091623062551\ \(0\)\
\-\ crura\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ vasculidity\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ erection\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ 40\\-85\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ kawanishi\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ nakanishi\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ kojima\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ numata\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ revasculariztaion\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ arteriogenic\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ 94\\.\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ attaining\\:\\ 0\\.03593969576728563\ \(0\)\
\-\ bju\\:\\ 0\\.03593969576728563\ \(0\)\
\-\ arteriograms\\:\\ 0\\.03414560236857694\ \(0\)\
\-\ compensate\\:\\ 0\\.03414560236857694\ \(0\)\
\-\ paired\\:\\ 0\\.03287267284445401\ \(0\)\
\-\ kimura\\:\\ 0\\.03287267284445401\ \(0\)\
\-\ right\\:\\ 0\\.03191616669417404\ \(0\)\
\-\ vasculopathy\\:\\ 0\\.03188531199793097\ \(0\)\
\-\ inflow\\:\\ 0\\.03188531199793097\ \(0\)\
\-\ absence\\:\\ 0\\.03144095783240365\ \(0\)\
\-\ abscence\\:\\ 0\\.03039649679164241\ \(0\)\
\-\ amenable\\:\\ 0\\.0298056499216224\ \(0\)\
\-\ effectiveness\\:\\ 0\\.0298056499216224\ \(0\)\
\-\ calculated\\:\\ 0\\.027329473868810794\ \(0\)\
\-\ efficacy\\:\\ 0\\.02647037645978001\ \(0\)\
\-\ international\\:\\ 0\\.02647037645978001\ \(0\)\
\-\ compromised\\:\\ 0\\.026217463124205018\ \(0\)\
\-\ issue\\:\\ 0\\.026217463124205018\ \(0\)\
\-\ long\\:\\ 0\\.026072756733032953\ \(0\)\
\-\ selective\\:\\ 0\\.025978227631858662\ \(0\)\
\-\ y\\:\\ 0\\.025978227631858662\ \(0\)\
\-\ internal\\:\\ 0\\.025352883817511253\ \(0\)\
\-\ notice\\:\\ 0\\.025132850478041365\ \(0\)\
\-\ subjective\\:\\ 0\\.02494453360008209\ \(0\)\
\-\ hypertrophied\\:\\ 0\\.024107179619380636\ \(0\)\
\-\ august\\:\\ 0\\.023275090099456126\ \(0\)\
\-\ caliber\\:\\ 0\\.022262516770124943\ \(0\)\
\-\ correct\\:\\ 0\\.02216307935485035\ \(0\)\
\-\ affecting\\:\\ 0\\.021040156696549024\ \(0\)\
\-\ 2004\\:\\ 0\\.020336330614116774\ \(0\)\
\-\ survival\\:\\ 0\\.020271734156501055\ \(0\)\
\-\ african\\:\\ 0\\.019729246005650028\ \(0\)\
\-\ analysis\\:\\ 0\\.01924606329784033\ \(0\)\
\-\ 36\\:\\ 0\\.018950968720412575\ \(0\)\
\-\ help\\:\\ 0\\.018856820939672378\ \(0\)\
\-\ occlusion\\:\\ 0\\.018856820939672378\ \(0\)\
\-\ arise\\:\\ 0\\.018719251970335957\ \(0\)\
\-\ somewhat\\:\\ 0\\.01858583144745681\ \(0\)\
\-\ surgery\\:\\ 0\\.01836282357840951\ \(0\)\
\-\ smaller\\:\\ 0\\.018330484909312352\ \(0\)\
\-\ american\\:\\ 0\\.01801144378585508\ \(0\)\
\-\ volume\\:\\ 0\\.017860154561305172\ \(0\)\
\-\ embolization\\:\\ 0\\.017607241225730177\ \(0\)\
\-\ term\\:\\ 0\\.01730196303331004\ \(0\)\
\-\ r\\:\\ 0\\.017172763233786754\ \(0\)\
\-\ medications\\:\\ 0\\.016865363354075395\ \(0\)\
\-\ difficulty\\:\\ 0\\.016835766061372753\ \(0\)\
\-\ arterial\\:\\ 0\\.01655019738377288\ \(0\)\
\-\ young\\:\\ 0\\.01646800098743246\ \(0\)\
\-\ causing\\:\\ 0\\.016334311701607252\ \(0\)\
\-\ thrombosis\\:\\ 0\\.016230194456429405\ \(0\)\
\-\ limited\\:\\ 0\\.015955895004978217\ \(0\)\
\-\ traumatic\\:\\ 0\\.015836621509453756\ \(0\)\
\-\ rate\\:\\ 0\\.014737705710070102\ \(0\)\
\-\ subsequent\\:\\ 0\\.014719383618627485\ \(0\)\
\-\ n\\/a\\:\\ 0\\.013695604634332241\ \(0\)\
\-\ 3\\.\\:\\ 0\\.012937496513897024\ \(0\)\
\-\ inferior\\:\\ 0\\.012828833457340986\ \(0\)\
\-\ flow\\:\\ 0\\.012495813614418212\ \(0\)\
\-\ bilaterally\\:\\ 0\\.012419049727981872\ \(0\)\
\-\ post\\:\\ 0\\.011906349703859707\ \(0\)\
\-\ patient\\:\\ 0\\.011370689348447628\ \(0\)\
\-\ to\\:\\ 0\\.011338091374592555\ \(0\)\
\-\ demonstrated\\:\\ 0\\.011094778683437908\ \(0\)\
\-\ \\,\\:\\ 0\\.010780489334759231\ \(0\)\
\-\ secondary\\:\\ 0\\.010570929055348706\ \(0\)\
\-\ the\\:\\ 0\\.010399282477706367\ \(0\)\
\-\ blood\\:\\ 0\\.010320402975704865\ \(0\)\
\-\ are\\:\\ 0\\.010308618340969926\ \(0\)\
\-\ patients\\:\\ 0\\.009785728315778876\ \(0\)\
\-\ for\\:\\ 0\\.009678426751894448\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.009292632909875297\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00911393584947895\ \(0\)\
\-\ without\\:\\ 0\\.008902713125478585\ \(0\)\
\-\ or\\:\\ 0\\.008863033176669978\ \(0\)\
\-\ \\%\\:\\ 0\\.008820004572327468\ \(0\)\
\-\ demonstrates\\:\\ 0\\.008259385848022946\ \(0\)\
\-\ had\\:\\ 0\\.008158627518764196\ \(0\)\
\-\ male\\:\\ 0\\.006837192645519793\ \(0\)\
\-\ that\\:\\ 0\\.00653088817946382\ \(0\)\
\-\ by\\:\\ 0\\.00629588895241095\ \(0\)\
\-\ of\\:\\ 0\\.005670538976893242\ \(0\)\
\-\ from\\:\\ 0\\.005603697845815099\ \(0\)\
\-\ a\\:\\ 0\\.005264599139184973\ \(0\)\
\-\ history\\:\\ 0\\.005222188219942847\ \(0\)\
\-\ \\:\\:\\ 0\\.005001215999958695\ \(0\)\
\-\ this\\:\\ 0\\.004252819527938642\ \(0\)\
\-\ year\\:\\ 0\\.004230554288818206\ \(0\)\
\-\ old\\:\\ 0\\.003871392021514401\ \(0\)\
\-\ in\\:\\ 0\\.0037291790277898668\ \(0\)\
\-\ is\\:\\ 0\\.002488012293737724\ \(0\)\
\-\ and\\:\\ 0\\.0023895000760913955\ \(0\)\
\-\ \\.\\:\\ 0\\.0018849311202130765\ \(0\)\
\-\ with\\:\\ 0\\.0010354351866361923\ \(0\)\
